SEARCH
JSB Market Research: Xalkori (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022
Michaeldellk22
2014-06-24
Views
10
Description
Share / Embed
Download This Video
Report
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x205xsv" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:57
Prognostic role of KRAS mutation in non-small-cell lung cancer - Eur. Lung Cancer Conference 201...
05:26
Selecting a Laboratory for Molecular Testing in Non-Small Cell Lung Cancer
03:10
Lung Cancer Staging Non-small Cell
05:04
Maintenance Therapy in Non-Small Cell Lung Cancer
13:53
How to Treat Non-Small Cell Lung Cancer
00:43
Therapeutic Landscape of Small-Cell Lung Cancer Market Covered in a Study
00:14
JSB Market Research : Solid Oxide Fuel Cell Market by Type, Application, Geography - Global Trends & Forecast to 2018
03:49
Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
00:17
JSB Market Research: EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023
00:48
Small Cell Lung Cancer Staging
00:25
[PDF] Complementary/Holistic Medicine for Small Cell Lung Cancer - It s Your Life, Live It!
07:06
How to Treat Small Cell Lung Cancer
